SEC Form 4 · accession 0001053369-16-000035
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeenarine Narine
Director
Period of report
Oct 30, 2015
Accepted (ET)
Jan 8, 2016 · 12:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 30, 2015 | J | 398,840 | $0.00 | A | 398,840 | I | by Entity |
| Common Stock | Dec 31, 2015 | G | 6,000,000 | $0.00 | D | 12,262,006 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.0625 | Dec 31, 2015 | G | 6,000,000 | D | Mar 31, 2011 | Mar 31, 2018 | Common Stock | 6,000,000 | 3,910,532 | D |
Explanation of responses
- F1Milestone payment from company pursuant to a Strategic Alliance Agreement with Entity.
- F2Shares eventually transferred directly to reporting person.